CD44 and inflammatory breast carcinoma: Additionally, MIF- (CD74 + CD44) and MIF- (CD74 + CXCR4) signalings were augmented between malignant epithelial cells and myeloid/monocytes, as well as between T/NK cells and myeloid/monocytes in IBC samples (Figures 4G, H).